Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Using a new dental gel to improve gum health after cleaning

Official title: Randomized Control Trial of a Novel Dental Gel as an Adjunct to Scaling and Root Planing in Subjects With Stage II and III Periodontitis

Run by University of Alabama at Birmingham · NCT05384132 · Data updated 2026-11-12

This study is testing if a new dental gel can help people with gum disease get even better results after their teeth cleaning treatment.

More Periodontal Diseases trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment76 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedOctober 14, 2022
Main results expectedOctober 30, 2027
Study endsOctober 30, 2028
Registry record updatedDecember 17, 2025
Trial IDNCT05384132 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with stage II or III, Grade B periodontitis and specific periodontal conditions.

Probably not a fit

Patients who are pregnant, breastfeeding, or have received recent periodontal treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Livionex Dental Gel (LDG) as a home care product to enhance the results of scaling and root planing (SRP) in patients with periodontitis. SRP is a standard dental procedure aimed at removing plaque and tartar from teeth to alleviate gum disease. The study aims to determine if the addition of LDG can further reduce probing pocket depth beyond what is achieved with SRP alone. Participants will be monitored for their oral health and adherence to the treatment protocol throughout the study.

Why it matters

Potential benefit: If successful, this approach could lead to improved gum health and reduced periodontal disease progression for patients.

How similar studies have gone: Other studies have shown promise in using adjunctive therapies for periodontal treatment, but the specific use of LDG is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female subjects at least 18 years of age.

  * Subject must be willing and able to provide written informed consent.
  * Available during the course of the study.
  * Must have minimum of 20 natural teeth, excluding third molars.
  * Must have at least 20 BOP sites, excluding third molars.
  * Stage II or III, Grade B periodontitis with at least 4 teeth with a minimum PD of 5 mm and minimum CAL of 3mm.
  * No antibiotic therapy for periodontal disease or chronic use of anti-inflammatory drugs (NSAIDs) within the past month of Baseline, or during the study.
  * Must not have received definitive treatment (i.e., SRP or periodontal surgical therapy) for periodontitis in the last one year.
  * Subject must be willing and able to comply with study visits as described in the protocol.
  * Subjects must be available for follow up on the telephone.
  * Able to read and understand the consent form in English

Exclusion Criteria:

* • Pregnancy or breast feeding.

  * Medical condition that requires pre-medication prior to dental procedures.
  * Systemic conditions and use of medications that may affect periodontal tissues.
  * Severe dental disease characterized multiple decayed, untreated dental sites.
  * Presence of orthodontic appliances.
  * Diseases of oral soft or hard tissues.
  * Participating in another clinical trial currently or in the month preceding this study.
  * Stage IV and/or Grade C periodontitis.
  * Vertical bone defects 4mm or greater.
  * Subjects who have active dental infections other than periodontitis that will require dental treatment during the study period.
  * Excessive oral hygiene practices including use of water irrigation devices such as Waterpik or use of interdental cleansers more than twice daily.
  * Non-English speaking
  * Smokers, uncontrolled or brittle diabetics, HIV/AIDS, and subjects with severe systemic disease, e.g., cancer, lupus, pemphigus vulgaris/pemphigoid, or other oral mucous membrane diseases that would interfere with performance of oral hygiene, e.g., erosive lichen planus, recurrent major aphthous lesions, etc.
  * History of allergic reaction to any ingredient in the test/control dentifrices.
  * Presence of any condition, abnormality, or situation at Baseline that in the opinion of the Principal Investigator may preclude the subject's ability to comply with study requirements, including completion of the study or the quality of the data.
  * Subjects unwilling to use manual toothbrush during the study.

Where it's running

  • Unversity of Alabama at Birmingham, School of Dentistry
    Birmingham, Alabama, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.